Arthur Przybyl, President and CEO at ANI PHARMACEUTICALS INC (ANIP), sold 37,455 shares at $66.97 ($2.5M) on 2016-08-22, disclosed to the SEC on 2016-08-23.
Open-market sale of $2.5M ANIP by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANIP | SELL | 2019-03-20 | $179K | — | Filing → |
| ANIP | SELL | 2018-03-14 | $2.5M | — | Filing → |
| ANIP | SELL | 2018-03-05 | $1.5M | — | Filing → |